We are live on ! Find out more
FLACW

Frazier Lifesciences Acquisition Corporation Warrant
FLACW

Delisted

FLACW was delisted on the 22nd of November, 2022.

Back to rankings

24 hedge funds and large institutions have $3.4M invested in Frazier Lifesciences Acquisition Corporation Warrant in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more capital invested

Capital invested by funds: $2.4M → $3.4M (+$994K)

20% more funds holding

Funds holding: 20 → 24 (+4)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
24
Holders Change
+4
Holders Change %
+20%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MA
MYDA Advisors
New York
+$130K
2
EC
EcoR1 Capital
California
+$66.5K
3
PMAM
Picton Mahoney Asset Management
Ontario, Canada
+$33.3K
4
LCM
Laurion Capital Management
New York
+$16.6K

Top Sellers

Rank Fund Capital Flow
1
AC
Athanor Capital
New York
-$4.4K
2
MI
MMCAP International
Cayman Islands
-$100

FLACW Hedge Fund Activity: Q2 2021 in Review

24 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Warrant (FLACW) for Q2 2021, worth a combined $3.4M — up 41% from $2.4M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new FLACW positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was MYDA Advisors, opening a new position worth an estimated $130K. The largest seller was Athanor Capital, cutting an estimated $4.4K.

  • 24 institutional investors held Frazier Lifesciences Acquisition Corporation Warrant (FLACW) as of Q2 2021, up from 20 in Q1 2021.
  • Funds reported $3.4M of Frazier Lifesciences Acquisition Corporation Warrant stock for Q2 2021, up 41% quarter-over-quarter.
  • 4 funds opened new Frazier Lifesciences Acquisition Corporation Warrant positions in Q2 2021 and 0 closed out, a net change of +4 holders.
  • The largest Frazier Lifesciences Acquisition Corporation Warrant buyer in Q2 2021 was MYDA Advisors, an estimated $130K added.
  • The largest Frazier Lifesciences Acquisition Corporation Warrant seller in Q2 2021 was Athanor Capital, an estimated $4.4K sold.

Based on aggregated 13F filings for Q2 2021.